Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vericel

42.67
+0.19000.45%
Post-market: 42.670.0020+0.00%19:35 EDT
Volume:445.66K
Turnover:18.91M
Market Cap:2.15B
PE:820.99
High:42.81
Open:41.48
Low:41.40
Close:42.48
Loading ...

Esperion Therapeutics Inc expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
28 Feb

Vericel Price Target Maintained With a $60.00/Share by HC Wainwright & Co.

Dow Jones
·
28 Feb

Vericel Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.
·
28 Feb

Vericel Corp (VCEL) Q4 2024 Earnings Call Highlights: Record Revenue and Strong Growth Trajectory

GuruFocus.com
·
28 Feb

Q4 2024 Vericel Corp Earnings Call

Thomson Reuters StreetEvents
·
28 Feb

Stock Track | Vericel Plummets 5.11% After Missing Q4 Sales Estimates

Stock Track
·
28 Feb

Vericel Corp : Btig Cuts Target Price to $63 From $66

THOMSON REUTERS
·
28 Feb

Analysts Are Bullish on Top Healthcare Stocks: Vericel (VCEL), Astria Therapeutics (ATXS)

TIPRANKS
·
28 Feb

Vericel Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Vericel Corporation (VCEL) Tops Q4 Earnings Estimates

Zacks
·
27 Feb

Vericel Q4 Net Income, Revenue Increase; 2025 Revenue Growth Outlook Issued

MT Newswires Live
·
27 Feb

Vericel Q4 EPS $0.38 Beats $0.32 Estimate, Sales $75.38M Miss $76.47M Estimate

Benzinga
·
27 Feb

Earnings Flash (VCEL) Vericel Posts Q4 EPS $0.38, vs. FactSet Est of $0.32

MT Newswires Live
·
27 Feb

BRIEF-Vericel Q4 EPS USD 0.38

Reuters
·
27 Feb

Vericel Q4 Net Income USD 19.8 Million

THOMSON REUTERS
·
27 Feb

Vericel - Mid-Term Profitability Targets Increased to Gross Margin in High-70% Range and Adj Ebitda Margin in High-30% Range

THOMSON REUTERS
·
27 Feb

Vericel Corp : Qtrly Total Net Revenue of $75.4 Mln

THOMSON REUTERS
·
27 Feb

Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results

GlobeNewswire
·
27 Feb

Domino's Pizza Inc expected to post earnings of $4.90 a share - Earnings Preview

Reuters
·
21 Feb

Vericel Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
03 Feb